Kairos Pharma Ltd. (KAPA)
0.505
+0.03
(+6.65%)
USD |
NYAM |
Nov 03, 16:00
0.486
-0.02
(-3.76%)
After-Hours: 20:00
Kairos Pharma EPS Diluted (Quarterly) : -0.4536 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4536 |
| March 31, 2026 | -0.551 |
| December 31, 2025 | -0.4589 |
| September 30, 2025 | -0.4843 |
| June 30, 2025 | -0.5783 |
| March 31, 2025 | -0.5564 |
| December 31, 2024 | -0.4994 |
| September 30, 2024 | -0.5705 |
| June 30, 2024 | -0.1378 |
| Date | Value |
|---|---|
| March 31, 2024 | -0.176 |
| December 31, 2023 | -0.6092 |
| September 30, 2023 | -0.17 |
| June 30, 2023 | -0.1286 |
| March 31, 2023 | -0.0795 |
| December 31, 2022 | -0.1068 |
| September 30, 2022 | -0.1275 |
| June 30, 2022 | -0.2098 |
| March 31, 2022 | -0.128 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.388M |
| Total Expenses (Quarterly) | 1.388M |
| Enterprise Value | -1.080M |
| Earnings Yield | -385.7% |
| Normalized Earnings Yield | -372.44 |